Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults.

Clinical trial NCT00216450 · COMPLETED

Trial details

NCT number: NCT00216450
Sponsor: Janssen Cilag Pharmaceutica S.A.C.I., Greece
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Helicobacter Infections Bacterial Infections

Start date: 2004-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.